Skip to main content
. 2023 Mar 4;14(3):178. doi: 10.1038/s41419-023-05702-6

Fig. 5. TRIM56 expression promoted glioma cell migration and invasion via CDC42 activation.

Fig. 5

In U87 (A) and U251 (B) cells, the overexpression and knockdown of TRIM56 upregulated and inhibited CDC42 activation, respectively, with neither affecting total CDC42 expression. C Representative images of Transwell migration assays showing that knockdown of CDC42 or treatment with the CDC42 inhibitor ZCL278 (20 μM) reversed the effect of TRIM56 overexpression on glioma cell migration. D Representative images of Transwell invasion assays showing that knockdown of CDC42 or treatment with the CDC42 inhibitor ZCL278 (20 μM) reversed the effect of TRIM56 overexpression on glioma cell invasion.